Claybrook Capital’s Cigna CI Stock Holding History

Claybrook Capital’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-177	Closed	-$34K	–	180
2018 Q4	$34K	Buy	+177	New	+$36.9K	0.01%	292

Other funds holding CI

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Claybrook Capital's CI Position: Q1 2019 in Review

Claybrook Capital sold out of Cigna (CI) in Q1 2019, closing a stake of 177 shares — an estimated $34K sold.

Claybrook Capital first reported a position in CI in Q4 2018 and held it in 1 quarter. The position peaked at $34K in Q4 2018. 1,129 funds tracked by Wall St. Rank hold CI as of Q1 2019.

Claybrook Capital reported no remaining Cigna position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 177 Cigna shares in Q1 2019, an estimated $34K.
Claybrook Capital first reported a position in Cigna in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Cigna position peaked at $34K in Q4 2018.
1,129 funds tracked by Wall St. Rank held Cigna as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.